Document Detail

Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease.
MedLine Citation:
PMID:  16202852     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Hypertension is a common disease in patients with chronic kidney disease (CKD) and predisposes to heart disease, stroke, and progression of renal failure. In the general population, sodium restriction has been shown to improve blood pressure (BP) control, but this is not widely recommended in CKD patients. The aim of this study was to assess the sodium balance in a CKD clinic and its effect on BP management. METHODS: We retrospectively reviewed charts from June 1998 through to June 2003 and included all patients with an estimated glomerular filtration rate (GFR) of <30 mL/min who completed a 24-h urine collection for sodium. Patients were divided into tertiles based upon their 24-h sodium excretion and analyzed by ANOVA. RESULTS: We included 141 CKD patients who had a mean (+/- SE) sodium excretion of 145.7 +/- 4.7 mmol/day. There were a significantly greater number of antihypertensive agents used with increasing sodium excretion (2.00 +/- 0.16, 2.61 +/- 0.20, and 2.77 +/- 0.19 medications, respectively for each tertile; P = .01). This difference was even more prominent when only those patients with a GFR <or=15 mL/min (n = 77) were examined (1.69 +/- 0.19, 2.52 +/- 0.27, and 3.08 +/- 0.26 medications, respectively; P = .001). Control of BP was equivalent in all groups. Multivariable analysis revealed sodium excretion (P = .00005) and age (P = .007) to be significantly associated with use of antihypertensive medication. CONCLUSIONS: We have demonstrated that increased sodium intake is associated with an increased number of antihypertensive medications to achieve comparable BP control in a population with CKD.
Neil Boudville; Sharon Ward; Mark Benaroia; Andrew A House
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of hypertension     Volume:  18     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-10-05     Completed Date:  2006-02-28     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1300-5     Citation Subset:  IM    
Department of Medicine, University of Western Ontario, London, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / therapeutic use*
Biological Markers / urine
Blood Pressure / drug effects
Chronic Disease
Glomerular Filtration Rate / drug effects
Kidney Diseases / drug therapy*,  physiopathology,  urine
Middle Aged
Multivariate Analysis
Retrospective Studies
Sodium, Dietary / administration & dosage*,  urine
Treatment Outcome
Reg. No./Substance:
0/Antihypertensive Agents; 0/Biological Markers; 0/Sodium, Dietary

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Combination of site of infarct, unrecognized glucose intolerance, and reinfarction after acute myoca...
Next Document:  Peripartum hypertension from pheochromocytoma: a rare and challenging entity.